Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Share:
Related FRX
Activis Shares Languish Post-Forest Deal
Among A Raft Of Index Changes, Affiliated Managers Group To Join S&P 500
Related ENDP
Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain
US Stock Futures Up Ahead Of Economic Data
Endo completes acquisition of Auxilium (Seeking Alpha)

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at Forest Laboratories (NYSE: FRX) is $3.82 billion. Forest Laboratories' ROE for the same period is 9.98%.

The trailing-twelve-month revenue at Endo Health Solutions (NASDAQ: ENDP) is $3.03 billion. Endo Health's PEG ratio is 0.90.

The trailing-twelve-month revenue at Warner Chilcott plc (NASDAQ: WCRX) is $2.58 billion. Warner Chilcott had $304.00 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Dr. Reddy's Laboratories (NYSE: RDY) is $2.05 billion. Dr. Reddy's operating margin for the same period is 20.84%.

Posted-In: Drug Manufacturers-Other Industry Highest Revenue Mid-CapTrading Ideas

 

Related Articles (ENDP + FRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters